BRIV_adv
Annals of Indian Academy of Neurology
  Users Online: 2779 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size

Table of Contents
LETTERS TO THE EDITOR
Year : 2021  |  Volume : 24  |  Issue : 3  |  Page : 436-439
 

Unravelling diagnostic dilemma: AQP4-positive transverse myelitis mimics spinal intramedullary tumor


1 Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India
2 Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India
3 Department of Neuropathology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India

Date of Submission09-May-2020
Date of Acceptance09-Jun-2020
Date of Web Publication08-Jan-2021

Correspondence Address:
Dr. M Netravathi
Department of Neurology, National Institute of Mental Health & Neurosciences (NIMHANS), Hosur Road, Bangalore - 560 029, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aian.AIAN_424_20

Rights and Permissions

 



How to cite this article:
Ramalakshmi NS, Srinivas D, Mahadevan A, Netravathi M. Unravelling diagnostic dilemma: AQP4-positive transverse myelitis mimics spinal intramedullary tumor. Ann Indian Acad Neurol 2021;24:436-9

How to cite this URL:
Ramalakshmi NS, Srinivas D, Mahadevan A, Netravathi M. Unravelling diagnostic dilemma: AQP4-positive transverse myelitis mimics spinal intramedullary tumor. Ann Indian Acad Neurol [serial online] 2021 [cited 2021 Aug 3];24:436-9. Available from: https://www.annalsofian.org/text.asp?2021/24/3/436/306474




To Editor,

Intramedullary spinal cord lesions can result due to varied etiologies such as: infection (tuberculosis, syphilis, viruses, fungal, bacterial), demyelination (acute transverse myelitis, multiple sclerosis-MS, neuromyelitis optica spectrum disorders-NMOSD, ADEM-acute demyelinating encephalomyelitis, MOG-associated-disorders), granulomatous disorders, vascular, syringomyelia, congenital abnormalities, and neoplastic lesions.[1] NMOSD is characterized by repeated attacks of optic neuritis and myelitis. The severity of the neurological deficit and the imaging characteristics may mimic intramedullary spinal cord tumor.[1] Hereby, we describe three patients of AQP4-positive NMOSD misdiagnosed as intramedullary tumor and operated.

Patient-1: A 32-year-old gentleman presented with three episodes of recurrent neurological disturbances between 2003 and 2010 that improved with steroids. In 2013, he developed progressive quadriparesis, MRI showed a C2-C3 intramedullary lesion [Figure 1]; possibility of an intramedullary tumor was considered and C1-C3 laminectomy was done. Histopathology was suggestive of demyelination, was treated with steroids. Between 2004 and 2013, he had five more episodes. Totally he had three episodes of optic neuritis and six episodes of myelopathy. He was referred to our institute in Nov 2014. During that time, his neurological examination revealed visual acuity of 6/60 in the right eye and complete blindness in the left eye. Spastic right hemiparesis with 4/5 power and mild distal weakness in left hand. Deep tendon reflexes (DTRs) were brisk in all four limbs with bilateral extensor plantars. His evaluation revealed positive serum AQP4 antibody. He was diagnosed as AQP4-positive NMOSD and started on azathioprine.
Figure 1: MRI findings of the patients. (a, b) MRI images of the Case-1. (a) Sagittal T2 sequence showing the atrophies operated cervical spinal cord across the C2-C3. (b) Axial images of the same showing atrophied cord with T2 hyperintensity involving more than 50% of the cervical cord. (c, d) MRI images of the Case-2. (c) Sagittal T2 sequence showing the MRI changes prior to surgery showing T2 hyperintensity of the cervical cord with edematous cord. (d) Sagittal T2 sequence of the same patient 6 months after the surgery showing the atrophied thinned out cervical cord with brainstem changes across the Pons. (e-h) MRI images of the Case-3. Sagittal T2 sequence pre (e) and Post-surgery (f). (g, h) Axial images of the cervical cord showing T2 hyperintensity with bright spotty lesion

Click here to view


Patient-2: A 35-year-old lady presented with stiffness of both upper and lower limbs. MRI showed long segment expansile intramedullary lesion from medulla-T4 level [Figure 1]. The lesion was diagnosed as ependymoma/astrocytoma and she underwent C2–C6 laminectomy. Histopathology was suggestive of demyelinating disorder, serum was positive for AQP4 antibody. Post-surgery, she was subsequently evaluated by us. She had normal cranial nerve examination. Spasticity of all the four limbs with 0-1/5 power. DTRs were brisk with bilateral extensor plantars. She had decreased sensations below C5 with impaired vibration sense in the upper and lower limbs. She was treated with steroids, plasmapheresis, and Rituximab.

Patient-3: A 37-year-old farmer presented with progressive right-sided weakness of 15-days duration. Provisional diagnosis of C2-C5 intramedullary lesion- Pilocytic astrocytoma was made, C1-arch excision with C2-C4 laminectomy and spinal decompression was performed. Postoperative biopsy showed CD68-positive foamy macrophages suggestive of demyelination [Figure 2] following which was referred to us. He had normal cranial nerve examination. Spasticity of all the four limbs with 0/5 power. DTRs were brisk with bilateral extensor plantar response. He had decreased sensations below T2 with impaired vibration sense in the upper and lower limbs. He was diagnosed to have cervical myelopathy and evaluated. His serum and CSF AQP4-antibody were strongly positive. He was given steroids, plasmapheresis, and Cyclophosphamide.
Figure 2: Pathological changes of the Case-3 patient. Cord parenchyma showing large none of pallor (*) surrounded by sheets of foamy macrophages (arrow, a). Luxol fast blue highlights the focus of demyelination (*) (b). Aggregates of foamy macrophages (c), labelled by CD68 (d) are seen aggregating around blood vessels, with admixed lymphocytes labelled by LCA stain (e), that are predominantly CD3 positive T lymphocytes (f). [Magnification = scale bar, V = vessel]

Click here to view


All the patients in this case series had subacute onset of cervical myelopathy, were misdiagnosed as intramedullary neoplasm and were operated on. The first patient had steroid-responsive three episodes of recurrent neurological disturbances involving optic nerves and spinal cord. During the fourth episode he was suspected to have cervical cord ependymoma and operated. AQP4 was tested nearly 11 years after the onset of illness and diagnosed as NMOSD. The second and third patients had subacute onset of quadriparesis, both their MRI had shown T2-hyperintensity from cervicomedullary junction upto the cervical cord. Subacute onset, visual pathway involvement, recurrent neurological episodes, involvement of cervicomedullary junction on MRI and T2 bright spotty lesion on axial images were the diagnostic clues towards a demyelinating etiology.

There have been few cases previously where spinal cord lesions were suspected to be intramedullary tumors and operated. Brinar M et al.[2] reported five patients with spastic quadriparesis, biopsy was performed in two patients. The patients were diagnosed as NMO (1), MS (1), and ADEM (3). They found that demyelinating diseases involving the cord often exhibit the same clinical symptoms and signs as intramedullary tumors.[2] Oh SH et al.[1] reported a young female with bilateral upper limb weakness. Her MRI spine was suspected to be an ependymoma and a C2-6 laminectomy was done. Biopsy was suggestive of demyelination, serum AQP4 was positive suggestive of NMO. Habek M et al.[3] described a 43-year-old female patient with spastic quadriparesis. Spinal cord MRI revealed LETM (longitudinally extensive transverse myelitis) which was interpreted as a large intramedullary tumor. Biopsy revealed demyelination, serum was positive for NMO-IgG antibody.

Cohen et al.[4] reviewed spinal cord biopsies of 38 patients with progressive neurological deficits. MRI spine showed T2 hyperintense lesions in 92%, spinal cord expansion in 84%, and post-contrast patchy peripheral enhancement in 94%. Histopathology showed demyelination or sarcoidosis in 34%, spinal cord neoplasms in 21%, nonspecific changes in 26%, and one case each of TB and schistosomiasis. The treatment strategy was modified based on biopsy results in 26.3%.

It is important to clinically and radiologically distinguish demyelinating disorders from intramedullary spinal cord tumors[5] as described in [Table 1]. Imaging studies in AQP4-NMOSD reveal T2-hyperintense, T1-hypointense LETM as the most typical spinal cord lesion with three or more contiguous vertebral segment involvement.[6],[7] Cervical and thoracic cord are more frequently involved with preferential involvement of the central gray matter along the central canal of the spinal cord. When the cervical spine is involved, extension into the dorsal medulla/area postrema is commonly observed.[8] Apart from these, the presence of bright spotty lesions is a characteristic feature of AQP4-NMOSD. They are T2-hyperintense lesions on axial images, typically with higher signal intensity than that of the surrounding CSF.[6] Cord swelling and irregular enhancement is seen during the acute phase of AQP4-NMOSD on T1-weighted images, appearing as a combination of hypointense patchy areas and encasing ring-enhancing lesion resulting in a lens-shaped appearance on sagittal images.[7],[8] This distinctive enhancement pattern can be used to differentiate AQP4-NMOSD from other causes of LETM.
Table 1: Comparison between NMOSD & intramedullary spinal cord tumor

Click here to view


In Conclusion, clinical presentation of neoplastic and non-neoplastic spinal cord lesions could be similar. Though MRIs could be characteristic in most of the cases, some pose a diagnostic dilemma. When in doubt, it is better to empirically treat the patient for a month with steroids and repeat imaging than considering invasive procedures. But, considering empiric steroids before biopsy should be the last approach after exhausting every possible option since it might confound the biopsy results, decrease the yield, further delay diagnosis and one might miss the window of opportunity to diagnose and hence potentially mistreat patients. Hence, Clinicians should be aware of the differences in clinical and imaging features of NMOSD and intramedullary spinal cord tumor.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Oh S-H, Yoon K-W, Kim Y-J, Lee S-K. Neuromyelitis optica mimicking intramedullary tumor. J Korean Neurosurg Soc 2013;53:316-9.  Back to cited text no. 1
    
2.
Brinar M, Radoš M, Habek M, Poser CM. Enlargement of the spinal cord: Inflammation or neoplasm? Clin Neurol Neurosurg 2006;108:284-9.  Back to cited text no. 2
    
3.
Habek M, Adamec I, Brinar VV. Spinal cord tumor versus transverse myelitis. Spine J 2011;11:1143-5.  Back to cited text no. 3
    
4.
Cohen-Gadol AA, Zikel OM, Miller GM, Aksamit AJ, Scheithauer BW, Krauss WE. Spinal cord biopsy: A review of 38 cases. Neurosurgery 2003;52:806-16.  Back to cited text no. 4
    
5.
Barreras P, Fitzgerald KC, Mealy MA, Jimenez JA, Becker D, Newsome SD, et al. Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy. Neurology 2018;90:e12-21.  Back to cited text no. 5
    
6.
Yonezu T, Ito S, Mori M, Ogawa Y, Makino T, Uzawa A, et al. “Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis. Mult Scler J 2014;20:331-7.  Back to cited text no. 6
    
7.
Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: An International update. Neurology 2015;84:1165-73.  Back to cited text no. 7
    
8.
Flanagan EP. Neuromyelitis optica spectrum disorder and other non-multiple sclerosis central nervous system inflammatory diseases. Continuum (Minneap Minn). 2019;25:815-44.  Back to cited text no. 8
    


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1]



 

Top
Print this article  Email this article

    

 
   Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (1,606 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed312    
    Printed15    
    Emailed0    
    PDF Downloaded22    
    Comments [Add]    

Recommend this journal